LabCorp/LH

$216.18

0.33%
-
1D1W1MYTD1YMAX

About LabCorp

Laboratory Corporation of America Holdings provides comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and advance science to improve health and improve lives through its unparalleled diagnostics and drug development laboratory capabilities. The Company’s segments include Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). It offers menopause testing through its Labcorp OnDemand digital health platform. Labcorp OnDemand's Menopause Test aims to help individuals understand hormonal factors related to menopause in order to take proactive steps to address symptoms and have more informed conversations with providers. The Company, through its subsidiary, Ovia Health provides comprehensive programs for maternal health, family building, parental wellbeing, and menopause support.

Ticker

LH

Sector

Healthcare

Trading on

NYSE

Industry

Healthcare Facilities

CEO

Adam Schechter

Employees

80,000

Headquarters

Burlington, United States

LabCorp Metrics

BasicAdvanced
$18.39B
Market cap
47.10
P/E ratio
$4.65
EPS
1.02
Beta
$2.88
Dividend rate
1.31%
Dividend yield

What the Analysts think about LabCorp

Analyst Ratings

Majority rating from 18 analysts.
Buy

Price Targets

Average projection from 15 analysts.
14.26% upside
High $270.00
Low $220.00
$216.18
Current price
$247.00
Average price target

LabCorp Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-5.5% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$3.03B
-0.77%
Net income
$-167.1M
-191.16%
Profit margin
-5.5%
-191.82%

LabCorp Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 1.31%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$3.82
$3.42
$3.38
$3.30
-
Expected
$3.96
$3.53
$3.33
$3.26
$3.50
Surprise
-3.43%
-3.23%
1.42%
1.31%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell LabCorp stock

Buy or sell LabCorp stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing